Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangeeta Ray Banerjee

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Nanoscale|September 12, 2022
PSMA-specific degradable dextran for multiplexed immunotargeted siRNA therapeutics against prostate cancerZhihang Chen, Balaji Krishnamachary, Yelena Mironchik, et al.
Oncotarget|December 31, 2011
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Hassan Shallal, et al.
Nuclear Medicine and Biology|February 5, 2005
New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate designSangeeta Ray Banerjee, Kevin P Maresca, Lynn Francesconi, et al.
Angewandte Chemie (International Ed. in English)|June 25, 2013
Salicylic acid and analogues as diaCEST MRI contrast agents with highly shifted exchangeable proton frequenciesXing Yang, Xiaolei Song, Yuguo Li, et al.
Bioconjugate Chemistry|April 15, 2016
Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMASangeeta Ray Banerjee, Zhengping Chen, Mrudula Pullambhatla, et al.
Biochemical and Biophysical Research Communications|October 13, 2009
A low molecular weight PSMA-based fluorescent imaging agent for cancerYing Chen, Surajit Dhara, Sangeeta Ray Banerjee, et al.
Cancer Research|November 12, 2015
Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast CancerAnders Josefsson, Jessie R Nedrow, Sunju Park, et al.
Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.
Journal of Medicinal Chemistry|June 27, 2013
Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Nanoscale|September 12, 2022
PSMA-specific degradable dextran for multiplexed immunotargeted siRNA therapeutics against prostate cancerZhihang Chen, Balaji Krishnamachary, Yelena Mironchik, et al.
Oncotarget|December 31, 2011
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Hassan Shallal, et al.
Nuclear Medicine and Biology|February 5, 2005
New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate designSangeeta Ray Banerjee, Kevin P Maresca, Lynn Francesconi, et al.
Angewandte Chemie (International Ed. in English)|June 25, 2013
Salicylic acid and analogues as diaCEST MRI contrast agents with highly shifted exchangeable proton frequenciesXing Yang, Xiaolei Song, Yuguo Li, et al.
Bioconjugate Chemistry|April 15, 2016
Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMASangeeta Ray Banerjee, Zhengping Chen, Mrudula Pullambhatla, et al.
Biochemical and Biophysical Research Communications|October 13, 2009
A low molecular weight PSMA-based fluorescent imaging agent for cancerYing Chen, Surajit Dhara, Sangeeta Ray Banerjee, et al.
Cancer Research|November 12, 2015
Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast CancerAnders Josefsson, Jessie R Nedrow, Sunju Park, et al.
Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.
Journal of Medicinal Chemistry|June 27, 2013
Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Pageof 5